High levels of factor VIII and risk of extra-hepatic portal vein obstruction.

BACKGROUND/AIMS High levels of coagulation factor VIII are a risk factor for lower-limb deep vein thrombosis (DVT). Their role in extra-hepatic portal vein obstruction (EHPVO) is not established. METHODS Factor VIII was measured in 85 patients with EHPVO (primary in 58 and complicating liver cirrhosis in 27), in 200 with lower-limb DVT, in 108 with liver cirrhosis without thrombosis and in 200 healthy controls. RESULTS Factor VIII levels were significantly higher in patients with primary EHPVO (138 IU/dL, range 86-366), EHPVO and cirrhosis (147 IU/dL, 95-242), lower-limb DVT (140 IU/dL, 64-400) and cirrhosis alone (160 IU/dL, 43-446) than in controls (112 IU/dL, 62-250, p<0.001). When factor VIII exceeded 129 IU/dL (66th percentile), the odds ratios were 10.5 (95%CI 3.3-33.4) for primary EHPVO, 6.0 (1.2-30.7) for EHPVO and cirrhosis, 5.0 (2.6-9.4) for lower-limb DVT. After exclusion of the effect of the acute phase reaction, the odds ratio for primary EHPVO was 4.2 (0.8-22.7), and was 8.7 (0.9-80.5) after exclusion also of patients with chronic myeloproliferative disorders. CONCLUSIONS High factor VIII levels are independently associated with an increased risk for EHPVO. The risk of EHPVO increased with increasing factor VIII levels and was only partially dependent on the acute phase reaction.

[1]  A. Koshy,et al.  High FVIII level is associated with idiopathic portal vein thrombosis in South India. , 2007, The American journal of medicine.

[2]  A. Tosetto,et al.  Validated questionnaire for the identification of previous personal or familial venous thromboembolism. , 1996, American journal of epidemiology.

[3]  V. De Stefano,et al.  G20210A prothrombin gene mutation and other trombophilic polymorphisms in patients with portal or hepatic venous thrombosis. , 2001, Gastroenterology.

[4]  W. Aird,et al.  Vascular-bed--specific hemostasis and hypercoagulable states. , 1999, The New England journal of medicine.

[5]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[6]  P. Fontana,et al.  The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case–control study , 2004, Journal of thrombosis and haemostasis : JTH.

[7]  M. Margaglione,et al.  Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis , 2000, Hepatology.

[8]  I. Scharrer,et al.  Criteria for the Diagnosis of Lupus Anticoagulants: An Update , 1995, Thrombosis and Haemostasis.

[9]  F. Vleggaar,et al.  Factor V Leiden mutation, prothrombin gene mutation and deficiencies in coagulation inhibitors associated with Budd‐Chiari syndrome and portal vein thrombosis , 1998 .

[10]  M. Woodward,et al.  EPIDEMIOLOGY OF COAGULATION FACTORS, INHIBITORS AND ACTIVATION MARKERS: THE THIRD GLASGOW MONICA SURVEY I. ILLUSTRATIVE REFERENCE RANGES BY AGE, SEX AND HORMONE USE , 1997, British journal of haematology.

[11]  P. Reitsma,et al.  High Plasma Concentration of Factor VIIIc Is a Major Risk Factor for Venous Thromboembolism , 2000, Thrombosis and Haemostasis.

[12]  E. Elias,et al.  Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. , 1997, Gut.

[13]  F R Rosendaal,et al.  Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. , 2000, Blood.

[14]  M. Gianni,et al.  Inherited thrombophilic abnormalities and risk of portal vein thrombosis , 2008, Thrombosis and Haemostasis.

[15]  J. Vandenbroucke,et al.  Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.

[16]  D. Valla,et al.  Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. , 1988, Gastroenterology.

[17]  A. Tripodi,et al.  LIVER FAILURE AND LIVER DISEASE , 2005 .

[18]  D. Valla,et al.  Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. , 2000, Journal of hepatology.

[19]  M. Laffan,et al.  High Prevalence of Elevated Factor VIII Levels in Patients Referred for Thrombophilia Screening: Role of Increased Synthesis and Relationship to the Acute Phase Reaction , 1997, Thrombosis and Haemostasis.

[20]  A. LaCroix,et al.  Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women. , 2001, JAMA.

[21]  P. Mannucci,et al.  Factor VIII clotting activity , 1999 .

[22]  K. Reddy,et al.  Portal vein thrombosis: a concise review , 2002, American Journal of Gastroenterology.

[23]  I. Martinelli.  Risk Factors in Venous Thromboembolism , 2001, Thrombosis and Haemostasis.

[24]  P. Mannucci,et al.  Risk factors for thrombophilia in extrahepatic portal vein obstruction , 2005, Hepatology.

[25]  S. Harari,et al.  Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension. , 1997, Thrombosis research.

[26]  R. Bertina,et al.  Laboratory Techniques in Thrombosis — a Manual , 1999, Springer Netherlands.

[27]  D. Mohanty,et al.  Hereditary thrombophilia as a cause of Budd‐Chiari syndrome: A study from Western India , 2001, Hepatology.

[28]  D. Valla,et al.  Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors , 2000, Hepatology.

[29]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[30]  A. Dasgupta,et al.  Thrombophilic conditions in non-cirrhotic portal vein thrombosis. , 2005, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[31]  D. Valla,et al.  Etiology of portal vein thrombosis in adults , 1988 .

[32]  C. Gartung,et al.  Elevated levels of factor VIII:C as a possible risk factor for portal, splenic, and mesenteric vein thrombosis. , 2001, Gastroenterology.

[33]  F. Violi,et al.  Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. , 2005, The Journal of laboratory and clinical medicine.

[34]  M. Gaub,et al.  Frequent factor II G20210A mutation in idiopathic portal vein thrombosis. , 1999, Gastroenterology.

[35]  M. Laffan,et al.  Elevation of FVIII: C in Venous Thromboembolism Is Persistent and Independent of the Acute Phase Response , 2000, Thrombosis and Haemostasis.

[36]  A. Tripodi.  A review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia. , 2005, Seminars in thrombosis and hemostasis.

[37]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.